CTLA-4 blockade
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTLA-4 blockade, covering 2021-01-25 to 2021-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer [Phase 2]